FREER, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 6.287
EU - Europa 3.088
AS - Asia 1.589
AF - Africa 229
OC - Oceania 105
SA - Sud America 69
Totale 11.367
Nazione #
US - Stati Uniti d'America 5.992
IT - Italia 1.210
SE - Svezia 609
CN - Cina 532
GB - Regno Unito 259
BG - Bulgaria 252
CA - Canada 224
DE - Germania 199
TR - Turchia 161
ID - Indonesia 158
UA - Ucraina 145
VN - Vietnam 111
SG - Singapore 109
AU - Australia 89
CH - Svizzera 85
FI - Finlandia 85
PH - Filippine 83
CI - Costa d'Avorio 72
IR - Iran 65
IN - India 53
MX - Messico 47
PK - Pakistan 47
IQ - Iraq 46
HK - Hong Kong 43
KR - Corea 37
NG - Nigeria 35
EG - Egitto 34
SN - Senegal 34
FR - Francia 32
BR - Brasile 30
RU - Federazione Russa 29
MY - Malesia 28
BE - Belgio 25
SA - Arabia Saudita 24
JP - Giappone 21
IE - Irlanda 20
AT - Austria 19
RO - Romania 19
KE - Kenya 18
ES - Italia 17
NL - Olanda 17
NZ - Nuova Zelanda 16
GH - Ghana 15
TH - Thailandia 15
TW - Taiwan 15
CO - Colombia 13
LK - Sri Lanka 12
PL - Polonia 12
BS - Bahamas 11
SI - Slovenia 10
ZA - Sudafrica 9
AE - Emirati Arabi Uniti 8
AR - Argentina 8
HU - Ungheria 8
GR - Grecia 7
NO - Norvegia 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
HN - Honduras 5
LB - Libano 5
BD - Bangladesh 4
CR - Costa Rica 4
EC - Ecuador 4
PE - Perù 4
TN - Tunisia 4
CL - Cile 3
ET - Etiopia 3
HR - Croazia 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
IL - Israele 2
JO - Giordania 2
LV - Lettonia 2
OM - Oman 2
PS - Palestinian Territory 2
VE - Venezuela 2
BY - Bielorussia 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
PR - Porto Rico 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
SZ - Regno dello Swaziland 1
UG - Uganda 1
Totale 11.367
Città #
Woodbridge 691
Fairfield 617
Ann Arbor 561
Chandler 458
Houston 458
Ashburn 349
Milan 322
Seattle 253
Sofia 252
Wilmington 210
Cambridge 202
Jacksonville 202
Beijing 177
Serra 165
New York 153
Ottawa 153
Princeton 136
Izmir 135
Florence 133
Lawrence 103
Redwood City 97
Medford 96
Nanjing 87
Bern 77
Abidjan 72
Dearborn 61
San Diego 53
London 44
Des Moines 43
Nanchang 39
Jüchen 37
Rome 37
Dakar 34
Durham 34
Dong Ket 32
Hong Kong 32
Jakarta 32
Pisa 32
Washington 32
Kunming 28
Columbus 27
Singapore 27
Lagos 26
Sohag 25
Lancaster 22
Shenyang 22
Bremen 21
Brussels 21
Frankfurt am Main 21
Najaf 21
Vienna 20
Los Angeles 18
Hebei 17
Tehran 17
Changsha 16
Norwalk 16
Southborough 16
Sydney 16
Melbourne 15
Ogden 15
Rivalta di Torino 15
Surabaya 15
Accra 14
Cascina 14
Guangzhou 14
Iloilo City 14
Livorno 13
Shanghai 13
Arcadia 12
Jiaxing 12
Karachi 12
Chicago 11
Gainesville 11
Nassau 11
San Francisco 11
Falls Church 10
Hangzhou 10
Indianapolis 10
Islamabad 10
Ljubljana 10
Paris 10
Pune 10
Tianjin 10
Toronto 10
Wichita 10
Colorado Springs 9
Davao City 9
Detroit 9
Hefei 9
Miami 9
Subang Jaya 9
Arena 8
Auburn Hills 8
Bacolod City 8
Bangkok 8
Ho Chi Minh City 8
Mascouche 8
Milwaukee 8
Orange 8
Phoenix 8
Totale 7.546
Nome #
Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies 2.157
Evolution of viruses and the emergence of SARS-CoV-2 variants 158
COMPLETE RELEASE OF ADENOSINE-DEAMINASE FROM MOUSE LYMPHOCYTES STABILIZED BY LOW-PH ACETATE 150
Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes 147
The effects of feline immunodeficiency virus on feline monocyte derived dendritic cells infected by spinoculation. 147
Antibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity 140
Effects of feline immunodeficiency virus on feline monocyte-derived dendritic cells infected by spinoculation 138
Localization of T helper cell epitopes in the vesicular stomatitis virus: the nucleoprotein is responsible for serotype cross-reactive T help. 136
Effect of feline immunodeficiency virus on feline monocyte-derived dendritic cells derived for in vivo use. 136
Human Wharton's jelly-derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive properties 135
A comparison of various EIA plates for the analysis of poly-saccharide antigens and serological identification of Oral Streptococchi. New perspective on streptococci and streptococcal infections 131
A new fluorimetric assay to measure cytotoxic T-lymphocyte activity against feline immunodeficiency virus envelope glycoprotein 130
AIDS Vaccination Studies with an Ex Vivo Feline Immunodeficiency Virus Model: Analysis of the Accessory ORF-A Protein and DNA as Protective Immunogens 128
Identification and molecular cloning of a novel secretion antigen from Mycobacterium tuberculosis and Mycobacterium bovis BCG. 126
INDUCTION OF PROTECTIVE CYTOTOXIC T-CELLS WITH VIRAL-PROTEINS 124
Purification, biochemical characterization and immunogenicity of SA5K, a secretion antigen of Mycobacterium tuberculosis 123
QUESTIONING THE ROLE OF ADENOSINE-DEAMINASE IN THE DEVELOPMENT OF LYMPHOCYTE-B IN CHICKEN BURSA 121
Does lung microbiome play a causal or casual role in asthma? 121
PURINE METABOLISM AND B-LYMPHOCYTE DEVELOPMENT IN THE CHICKEN BURSA OF FABRICIUS 120
Development Of A Self-Inactivating Bicistronic Lentiviral Vector For Heterologous Primary Cells Transduction, 118
Color Atlas of Microbiology 118
Comparative analysis of subcellular distribution of protein antigens in Mycobacterium bovis Bacillus Calmette-Guerin 116
Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium 114
Env-Expressing Autologous T Lymphocytes Induce Neutralizing Antibody and Afford Marked Protection against Feline Immunodeficiency Virus 112
Prime-Boost Vaccination with DNA-Transduced Autologous Lymphocytes Protects Against Fully Virulent Homologous Challenge in the Feline Immunodeficiency Virus AIDS Model 111
Hepatitis viruses 111
Viral hepatitis 110
Characterization of antigens recognized by new monoclonal antibodies raised against culture filtrate proteins of Mycobacterium bovis bacillus Calmette-Guerin 110
Intracellular detection of interleukin 17 and other cytokines in human bronchoalveolar lavage fluid: A first assessment 107
The role of cytokines in T help responses to viruses 106
Mouse mammary tumour virus-like env nucleotide and p14 signal peptide are present in feline mammary carcinomas, but not in neoplastic or dysplastic canine mammary lesions 106
Evaluation of underreporting tuberculosis in Central Italy by means of record linkage. 105
Intracellular cytokine detection by fluorescence-activated flow cytometry: Basic principles and recent advances 104
IMPAIRED IMMUNE AND ACUTE-PHASE RESPONSES IN INTERLEUKIN-6-DEFICIENT MICE 103
Clonaggio molecolare di un nuovo antigene di secrezione di Mycobacterium tuberculosis e Mycobacterium bovis BCG 102
Generation of feline dendritic cells derived from peripheral blood monocytes for in vivo use 102
Virome and Inflammasomes, a Finely Tuned Balance with Important Consequences for the Host Health 102
Influence of Dendritic Cells on Viral Pathogenicity 101
Involvement of the fadD33 gene in the growth of Mycobacterium tuberculosis in the liver of BALB/c mice 99
Biodistribution patterns of native and mutant Tc-99m-labeled annexin V in mice. 98
Enhanced in vitro virus expression using 3-dimensional cell culture spheroids for infection 98
Tweaking Mesenchymal Stem/Progenitor Cell Immunomodulatory Properties with Viral Vectors Delivering Cytokines 95
Evaluation of T cell immunity against human cytomegalovirus: Impact on patient management and risk assessment of vertical transmission 95
NO RECOGNITION OF MHC CLASS II+ CELLS INFECTED WITH A VACCINIA VIRUS ENCODING INFLUENZA TYPE-A NUCLEOPROTEIN BY CLASS II-RESTRICTED T-CELLS 93
DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model 93
Development of feline immunodeficiency virus ORF-A (tat) mutants: In vitro and in vivo characterization 91
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 89
Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses 88
A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts 88
Identification of a novel Mycobacterium bovis BCG secretion protein 87
The virome and its major component, Anellovirus, a convoluted system moulding human immune defences and possibly affecting the development of asthma and respiratory diseases in childhood 87
CHARACTERIZATION OF T-HELPER EPITOPES OF THE GLYCOPROTEIN OF VESICULAR STOMATITIS-VIRUS 86
Human gamma-delta+ T cell responses to mycobacterial soluble extracts 86
Protopine/Gemcitabine Combination Induces Cytotoxic or Cytoprotective Effects in Cell Type-Specific and Dose-Dependent Manner on Human Cancer and Normal Cells 86
STRUCTURAL AND STEREOSPECIFIC REQUIREMENTS FOR THE NUCLEOSIDE-TRIGGERED GERMINATION OF BACILLUS-CEREUS SPORES 85
Biodistribution of native and mutant Annexin V in mice 84
Immunotherapy with internally inactivated virus loaded dendritic cells boosts cellular immunity but does not affect feline immunodeficiency virus infection course 84
The role of antibody concentration and avidity in antiviral protection 82
In vivo delivery of herpes simplex virus 1 glycoprotein B to vaccinate against genital herpes 82
In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients 82
Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans 81
The Virome and its Major Component, Anellovirus, a Convoluted System Molding Human Immune Defenses and Possibly Affecting the Development of Asthma and Respiratory Diseases in Childhood 81
TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology 81
In vivo delivery of herpes simplex type 1 glycoprotein B to vaccinate against genital herpes. 80
CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats 80
Cloning of an unidentified T-cell receptor alpha chain gene from a vesicular stomatitis virus-specific helper T-cell clone 79
Intracellular staining and detection of cytokines by fluorescence-activated flow cytometry 78
Hsp 60 promoter activity in recombinant Mycobacterium avium:LacZ during extra and intracellular growth 77
EPIDEMIOLOGIC SURVEY OF STREPTOCOCCUS-MUTANS IN A GROUP OF ADULT PATIENTS LIVING IN PISA (ITALY) 77
Sphingolipid/ceramide pathways and autophagy in the onset and progression of melanoma: Novel therapeutic targets and opportunities 76
null 75
Identification of a human immunodominant T-cell epitope of mycobacterium tuberculosis antigen PPE44 75
Acid ceramidase controls apoptosis and increases autophagy in human melanoma cells treated with doxorubicin 75
Role of env in resistance of feline immunodeficiency virus (FIV)-Infected cats to superinfection by a second FIV strain as determined by using a chimeric virus 74
Novel approaches to vaccination against the feline immunodeficiency virus 74
Ablation of acid ceramidase impairs autophagy and mitochondria activity in melanoma cells 73
Correlation of tolerogenicity of a viral antigen with its immunogenicity. (vol 158, pg 5106, 1997) 72
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody 72
Qualitative and quantitative requirements for CD4(+) T cell-mediated antiviral protection 70
Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus 70
Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein 69
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 69
In vivo delivery of Herpes simplex type-1 glycoprotein B by a lentiviral vector affords protection against genital herpes. 68
Identification and molecular cloning of a novel secretion antigen from Mycobacterium bovis BCG. 67
Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection 66
Interleukin 10 in Antiviral Responses 66
A low-cost simple test for weekly detection of Mycoplasma hyorhinis and arginini contaminations in cell cultures and viral preparations 66
Allestimento di un modello genetico per l'analisi quantitativa dell'attività di promotori micobatterici 64
Biologia e patogenesi dei virus epatite G e TT 61
Sviluppo di un vaccino contro herpes genitalis: analisi di risposta immune ed efficacia protettiva nel modello murino. 60
Role of spore coats in the germinative response of Bacillus cereus to adenosine and its analogues. 60
Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor 57
La vaccinazione con la glicoproteina B del virus Herpes Simplex tipo 1 protegge contro l’herpes genitale 52
M. Ponticelli, M.L. Bellone, V. Parisi, A. M. Iannuzzi, A. Braca, N. De Tommasi, D. Russo, A. Sileo, P. Quaranta, G. Freer, M. Pistello 51
Il ruolo di cefixima nella moderna terapia antibiotica 51
IMMUNOLOGY BY VIRUSES 51
Delivery of an Immunogen with a FIV vector confers substantial protection against genital herpes. 46
La vaccinazione con la glicoproteina B del virus Herpes Simplex tipo 1 protegge contro l’infezione sessualmente trasmessa 45
Protezione da herpes genitale attraverso vaccinazione con glicoproteina B di herpes simplex di tipo 1. 44
Zika virus induces FOXG1 nuclear displacement and downregulation in human neural progenitors 43
Totale 11.260
Categoria #
all - tutte 26.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019652 0 0 0 0 0 0 0 0 0 234 228 190
2019/20201.688 202 138 139 109 154 167 183 136 182 84 165 29
2020/20211.140 90 56 70 63 101 54 79 107 117 127 89 187
2021/20221.990 57 121 79 170 271 212 136 172 108 94 174 396
2022/20231.859 250 251 147 187 163 232 52 101 258 20 176 22
2023/20242.107 205 187 257 192 316 333 180 184 121 132 0 0
Totale 11.602